ADUSHealthcare · Medical Care FacilitiesThe 14 Wall Street analysts covering Addus HomeCare Corp. hold a median 12-month price target of $137 — +7.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 95 of 100 as at 3 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Addus HomeCare Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (85): The share price has been relatively steady.
Accruals (62): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (33): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on ADUS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +7.0% from it.
Of the 20 most recent actions, 2 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 Sept 2026 | B of A Securities | Downgrade | Neutral | $140 → $125 |
| 5 Aug 2026 | RBC Capital | Maintains | Outperform | $130 → $134 |
| 5 Aug 2026 | RBC Capital | Maintains | Outperform | — |
| 9 July 2026 | Barclays | Maintains | Underweight | $92 → $96 |
| 9 July 2026 | Barclays | Maintains | Underweight | — |
| 18 May 2026 | Citizens | Reiterates | Market Outperform | — |
| 15 May 2026 | Barclays | Maintains | Underweight | — |
| 6 May 2026 | Citizens | Maintains | Market Outperform | — |
| 25 Mar 2026 | Barclays | Maintains | Underweight | — |
| 25 Feb 2026 | Stephens & Co. | Maintains | Overweight | — |
| 24 Feb 2026 | Barclays | Maintains | Underweight | — |
| 13 Nov 2025 | BMO Capital | Initiates | Market Perform | — |
| 7 Nov 2025 | RBC Capital | Maintains | Outperform | — |
| 5 Nov 2025 | TD Cowen | Maintains | Buy | — |
| 4 Nov 2025 | Barclays | Maintains | Underweight | — |
| 3 Sept 2025 | Stephens & Co. | Reiterates | Overweight | — |
| 2 Sept 2025 | UBS | Initiates | Buy | — |
| 22 Aug 2025 | RBC Capital | Maintains | Outperform | — |
| 19 Aug 2025 | Barclays | Maintains | Underweight | — |
| 6 Aug 2025 | TD Cowen | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
ADUS appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Addus HomeCare Corp. returned +14.1% against +12.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 34% of US stocks
Cheaper than 57% of US stocks
Cheaper than 43% of US stocks
Cheaper than 25% of US stocks
Higher than 48% of US stocks
Higher than 63% of US stocks
Higher than 37% of US stocks
Higher than 64% of US stocks
Higher than 64% of US stocks
Higher than 62% of US stocks
Higher than 82% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Addus HomeCare Corp. has a market value of $2.3B and an enterprise value of $2.3B.
Revenue in the twelve months to 30 June 2026: $1.5B. The latest quarter grew 8.0% year on year.
Net income over the same four quarters: $105.3M, a 7.1% net margin.
Diluted earnings per share, trailing twelve months: $5.67.
Free cash flow in the twelve months to 30 June 2026: $154.8M.
Trailing P/E: 22.0×; forward P/E: 16.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Addus HomeCare Corp. employs 5,982 people — $247K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Addus HomeCare Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Addus HomeCare held its Q3 2026 earnings conference call on November 4, 2026. The excerpt lists company executives and participating analysts but provides no discussion of results or business developments.
Why it matters — The transcript identifies the event and participants, but the supplied excerpt contains no substantive operating or financial information for ADUS watchers.
Addus HomeCare reported third-quarter 2026 revenue of $387.7 million, up 7% year over year, and adjusted earnings per diluted share of $1.83, up 17.3%. Adjusted EBITDA rose 13.5% to $51.2 million, with the company citing cost discipline and operating leverage.
Why it matters — The results show earnings growth outpaced revenue growth, a development ADUS watchers may track when assessing the company’s operating performance.
Zacks Investment Research says Addus HomeCare’s revenue and EPS provide a view of its performance for the quarter ended September 2026, and points to comparing key metrics with Wall Street estimates and year-ago figures.
Why it matters — These comparisons offer ADUS watchers additional context for assessing quarterly performance.
Addus HomeCare reported quarterly earnings of $1.83 per share, above the Zacks Consensus Estimate of $1.78. Earnings were $1.56 per share in the year-ago quarter.
Why it matters — The report gives ADUS watchers a comparison of quarterly earnings with both analyst consensus and the year-ago period.
Addus HomeCare reported third-quarter 2026 net service revenues of $387.7 million, up 7.0%, and net income of $28.6 million, or $1.54 per diluted share. Adjusted diluted earnings per share rose 17.3% year over year to $1.83, while adjusted EBITDA increased 13.5% to $51.2 million.
Why it matters — The results provide ADUS watchers with updates on quarterly revenue, earnings, and adjusted EBITDA performance.
The 14 Wall Street analysts covering Addus HomeCare Corp. have a median 12-month price target of $137, with estimates ranging from $96 to $155. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Addus HomeCare Corp., 11 rate it a Buy, 2 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Addus HomeCare Corp. 95 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, Addus HomeCare Corp. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (85 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +7.0% from the last close, and Ticker Nerd's factor model ranks Addus HomeCare Corp. 95 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Addus HomeCare Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ADUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $96 to $155 over the next 12 months.
Addus HomeCare Corp. returned +14.1% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals.
The most recent item we track (Seeking Alpha, 4 Nov 2026): "Addus HomeCare Corporation (ADUS) Q3 2026 Earnings Call Transcript". Addus HomeCare held its Q3 2026 earnings conference call on November 4, 2026. The excerpt lists company executives and participating analysts but provides no discussion of results or business developments.
Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals. Addus HomeCare Corporation provides personal care, hospice, and home health services designed to support daily living, comfort, and clinical needs in the home setting. Its personal care services include non-medical assistance with activities such as bathing, grooming, dressing, meal support, and medication reminders, while its hospice and home health offerings address end-of-life support and medically supervised care after illness or hospitalization. The company serves patients through a broad network of locations across multiple states and works with government agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare Corporation plays an important role in the home care market by helping clients remain in familiar surroundings while receiving essential support services.
CEO Mr. R. Dirk Allison CPA · 5,982 employees · United States · https://www.addus.com
